Developing the role of pharmacists as members of community mental health teams: Perspectives of pharmacists and mental health professionals

Research in Social and Administrative Pharmacy

Volumn 3, Issue 4, 2007, Pages 392-409

  Bell, J Simon ^a,b   Rosen, Alan ^a,c,d   Aslani, Parisa ^a   Whitehead, Paula ^e   Chen, Timothy F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF HELSINKI   (Finland)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d UNIVERSITY OF WOLLONGONG   (Australia)

^e CURTIN UNIVERSITY   (Australia)

Author keywords

Antipsychotic agents; Community mental health services; Pharmaceutical services; Psychotropic drugs

Indexed keywords

PSYCHOTROPIC AGENT;

ALTERNATIVE MEDICINE; ARTICLE; AUSTRALIA; CASE MANAGEMENT; DRUG MONITORING; HEALTH CARE QUALITY; HUMAN; MEDICAL RECORD; MENTAL DISEASE; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PHARMACIST; PRESCRIPTION; PUBLIC RELATIONS; STANDARD;

AUSTRALIA; CASE MANAGEMENT; COMMUNITY MENTAL HEALTH SERVICES; COMPLEMENTARY THERAPIES; DRUG MONITORING; HUMANS; INTERPROFESSIONAL RELATIONS; MEDICAL RECORDS; MENTAL DISORDERS; PATIENT CARE TEAM; PHARMACISTS; PRESCRIPTIONS, DRUG; PSYCHOTROPIC DRUGS; QUALITY ASSURANCE, HEALTH CARE;

EID: 36849085362     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2006.10.005     Document Type: Article

References (53)

1. Mond J., Morice R., Owen C., and Korten A.E. Use of antipsychotic medications in Australia between July 1995 and December 2001. Aust N Z J Psychiatry 37 (2003) 55-61
2. McManus P., Mant A., Mitchell P.B., Montgomery W.S., Marley J., and Auland M.E. Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Med J Aust 173 (2000) 458-461
3. Bell S., McLachlan A.J., Aslani P., Whitehead P., and Chen T.F. Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Aust New Zealand Health Policy 2 (2005) Article 29
4. Finley P.R., Crismon M.L., and Rush A.J. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy 23 (2003) 1634-1644
5. Bell J.S., Aslani P., McLachlan A.J., Whitehead P., and Chen T.F. Mental health case conferences in primary care: content and treatment decision making. Res Soc Adm Pharm (2007) 86-103
6. Bell J.S., Whitehead P., Aslani P., McLachlan A.J., and Chen T.F. Drug related problems in the community setting: pharmacists' findings and recommendations for people with mental illnesses. Clin Drug Invest 26 (2006) 415-425
7. Harvey C.A., and Fielding J.M. The configuration of mental health services to facilitate care for people with schizophrenia. Med J Aust 178 (2003) S49-S52
8. Colombo A., Bendelow G., Fulford B., and Williams S. Evaluating the influence of implicit models of mental disorder on processes of shared decision making within community-based multi-disciplinary teams. Soc Sci Med 56 (2003) 1557-1570
9. Hickie I.B. Can we reduce the burden of depression? The Australian experience with beyondblue: the national depression initiative. Australas Psychiatry 12 (2005) S38-S46
10. Herrman H., Trauer T., and Warnock J. The roles and relationships of psychiatrists and other service providers in mental health services. Aust N Z J Psychiatry 36 (2002) 75-80
11. Liberman R.P., Hilty D.M., Drake R.E., and Tsang H.W.H. Requirements for multidisciplinary teamwork in psychiatric rehabilitation. Psychiatr Serv 52 (2001) 1331-1342
12. Rosen A., and Callaly T. Interdisciplinary teamwork and leadership: issues for psychiatrists. Australas Psychiatry 13 (2005) 234-240
13. Rosen A. The community psychiatrist of the future. Curr Opin Psychiatry 19 (2006) 380-388
14. Howard R. Impact of a pharmaceutical care program at a mental health clinic. Aust J Hosp Pharm 26 (1996) 250-253
15. Buhrich N., Butchart A., Johnston S., and Lauchlan R. Delivery of medication to psychiatric patients in community health services in New South Wales. Aust N Z J Psychiatry 30 (1996) 523-530
16. Stimmel G.L. Clinical pharmacy practice in a community mental health center. J Am Pharm Assoc (Wash) 15 (1975) 400-401 418
17. Branford D. Is there a role for community pharmacists in community psychiatry?. Pharm J 269 (2002) 842
18. Gray D.R., Namikas E.A., Sax M.J., et al. Clinical pharmacists as allied health care providers to psychiatric patients. Contemp Pharm Pract 2 (1979) 108-116
19. Watson P.J. Community pharmacists and mental health: an evaluation of two pharmaceutical care programmes. Pharm J 258 (1997) 419-422
20. Keks N.A., Alston K., Hope J., et al. Use of antipsychotics and adjunctive medications by an inner urban community psychiatric service. Aust N Z J Psychiatry 33 (1999) 896-901
21. Snowdon J., Day S., and Baker W. Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Int J Geriatr Psychiatry 20 (2005) 1146-1152
22. Oborne C.A., Hooper R., Chi Li K., Swift C.G., and Jackson S.H.D. An indicator of appropriate neuroleptic prescribing in nursing homes. Age Ageing 31 (2002) 435-439
23. Owen R.R., Thrush C.R., Kirchner J.E., Fischer E.P., and Booth B.M. Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose. Int J Qual Health Care 12 (2000) 475-482
24. Leslie D.L., and Rosenheck R.A. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: individual and facility predictors. Med Care 39 (2001) 923-933
25. Harrington M., Lelliott P., Paton C., Okocha R., Duffett R., and Sensky T. The results of a multi-centre audit of prescribing of antipsychotic drugs for inpatients in the UK. Psychiatr Bull 26 (2002) 414-418
26. Paton C., and Lelliott P. The use of prescribing indicators to measure the quality of care in psychiatric inpatients. Qual Saf Health Care 13 (2004) 40-45
27. Meagher D., and Moran M. Sub-optimal prescribing in an adult community mental health service: prevalence and determinants. Psychiatr Bull 27 (2003) 266-270
28. Callaly T., and Trauer T. Patterns of use of antipsychotic medication in a regional community mental health service. Australas Psychiatry 8 (2000) 220-224
29. Taylor D., Paton C., and Kerwin R. The Maudsley 2005-2006 Prescribing Guidelines (2005), Taylor and Francis, London
30. Centorrino F., Goren J.L., Hennen J., Salvatore P., Kelleher J.P., and Baldessarini R.J. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry 161 (2004) 700-706
31. Centorrino F., Fogarty K.V., Sani G., et al. Use of combinations of antipsychotics: McLean Hospital inpatients 2002. Hum Psychopharmacol 20 (2005) 485-492
32. Taylor D., Young C., Esop R., Paton C., and Walwyn R. Testing for diabetes in hospitalised patients prescribed antipsychotic drugs. Br J Psychiatry 185 (2004) 152-156
33. Merrill D.B., Dec G.W., and Goff D.C. Adverse cardiac effects associated with clozapine. J Clin Psychopharmacol 25 (2005) 32-41
34. Happell B., Manias E., and Roper C. Wanting to be heard: mental health consumers' experiences of information about medication. Int J Ment Health Nurs 13 (2004) 242-248
35. Ewan M., Greene R., and Anderson C. A qualitative investigation of the potential role of the community pharmacist in the care of the long term mentally ill. [abstract]. Pharm J 261 (1998) R61
36. Paton C., and Gill-Banham S. Prescribing errors in psychiatry. Psychiatr Bull 27 (2003) 208-210
37. Harris D., and Anderson C. Interventions by community pharmacists for older people with mental health problems: are they appropriate?. [abstract]. Int J Pharm Pract 11 (2003) R56
38. Kettle J., Downie G., Palin A., and Chesson R. Pharmaceutical care activities within a mental health team. Pharm J 257 (1996) 814-816
39. Ewan M.A., and Greene R.J. Evaluation of mental health care interventions made by three community pharmacists-a pilot study. Int J Pharm Pract 9 (2001) 225-234
40. Smith F.J. Research Methods in Pharmacy Practice (2002), Pharmaceutical Press, London
41. Campbell M., Fitzpatrick R., Haines A., et al. Framework for design and evaluation of complex interventions to improve health. Br Med J 321 (2000) 694-696
42. Bell J.S., Whitehead P., Aslani P., Sacker S., and Chen T.F. Design and implementation of an educational partnership between community pharmacists and consumer educators in mental health care. Am J Pharm Educ 70 (2006) Article 28
43. Punch K. Introduction to Social Research: Quantitative and Qualitative Approaches. 2nd ed. (2005), Sage Publications, London
44. Haynes B., and Haines A. Barriers and bridges to evidence based clinical practice. Br Med J 317 (1998) 272-276
45. DeVane C.L. Drug interactions and antipsychotic therapy. Pharmacotherapy 16 (1996) 15-20
46. DeVane C.L. Antidepressant-drug interactions are potentially but rarely clinically significant. Neuropsychopharmacology 31 (2006) 1605-1612
47. Carney S.L. Medication accuracy and general practitioner referral letters. Intern Med J 36 (2006) 132-134
48. Morris L., and Chen T.F. Enhancing communication between hospital and community: multidisciplinary discharge case conferences. Pharm World Sci 27 (2005) 71-72
49. Shaw H., Mackie C.A., and Sharkie I. Evaluation of effect of pharmacy discharge planning on medication problems experienced by discharged acute admission mental health patients. Int J Pharm Pract 8 (2000) 144-153
50. Callaly T., and Fletcher A. Providing integrated mental health services: a policy and management perspective. Australas Psychiatry 13 (2005) 351-356
51. Horner D., and Asher K. General practitioners and mental health staff sharing patient care: working model. Australas Psychiatry 13 (2005) 176-180
52. Kyle G., and Nissen L. A community nurse referral system for HMRs-can it work?. Aust Pharm 25 (2006) 326-332
53. Rychetnik L., Frommer M., Hawe P., and Shiell A. Criteria for evaluating evidence on public health interventions. J Epidemiol Community Health 56 (2002) 119-127